Skip to main content

Table 2 Experimental groups and timeline. Distribution of a total of 96 mice 6- and 12-month-old 5xFAD and age-matched WT mice for each procedural group. All mice were treated orally with SLCP (100 mg/kg BW) every other day for 2 months. IF immunofluorescent, GC Golgi-Cox, FJC fluoro-jade C, m month

From: RETRACTED ARTICLE: Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer’s amyloidosis

Groups

Group (m)

Behavior

CV stain

GC stain

Histochemistry

Western blot

WT + vehicle

6

12 (M = 4, F = 2)

3 (M = 2, F = 1)

6 (M = 4, F = 2)

3 (M = 2, F = 1)

3 (M = 2, F = 1)

5xFAD + vehicle

6

12 (M = 4, F = 2)

3 (M = 1, F = 2)

3 (M = 1, F = 2)

3 (M = 2, F = 1)

3 (M = 2, F = 1)

5xFAD + SLCP

6

12 (M = 2, F = 4)

3 (M = 2, F = 1)

3 (M = 2, F = 1)

3 (M = 1, F = 2)

3 (F = 3)

WT + SLCP

6

12 (M = 4)

3 (M = 1, F = 2)

6 (M = 3, F = 3)

3 (M = 1, F = 2)

3 (M = 2, F = 1)

WT + vehicle

12

11 (M = 6, F = 5)

3 (M = 2, F = 1)

3 (M = 2, F = 1)

3 (M = 2, F = 1)

3 (M = 1, F = 2)

5xFAD + vehicle

12

10 (M = 6, F = 4)

3 (M = 2, F = 1)

6 (M = 2, F = 4)

3 (M = 2, F = 1)

3 (M = 2, F = 1)

5xFAD + SLCP

12

11 (M = 7, F = 4)

3 (M = 1, F = 2)

3 (M = 1, F = 2)

3 (M = 1, F = 2)

3 (M = 1, F = 2)

WT + vehicle

12

10 ((M = 6, F = 4)

3 (M = 2, F = 1)

6 (M = 2, F = 1)

3 (M = 2, F = 1)

3 (M = 1, F = 2)